Fate Therapeutics, Inc. Share Price
FATEFate Therapeutics, Inc. Stock Performance
Open $1.27 | Prev. Close $1.31 | Circuit Range N/A |
Day Range $1.23 - $1.27 | Year Range $0.91 - $1.93 | Volume 38,530 |
Average Traded $1.24 |
Fate Therapeutics, Inc. Share Price Chart
About Fate Therapeutics, Inc.
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Fate Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Apr-26 | $1.27 | $1.25 | +0.00% |
29-Apr-26 | $1.27 | $1.25 | -4.94% |
28-Apr-26 | $1.30 | $1.31 | +0.00% |
27-Apr-26 | $1.35 | $1.31 | -1.50% |
24-Apr-26 | $1.33 | $1.33 | +0.75% |
23-Apr-26 | $1.39 | $1.32 | -3.28% |
22-Apr-26 | $1.39 | $1.37 | +0.74% |
FAQs on Fate Therapeutics, Inc. Share Price
Can I buy Fate Therapeutics, Inc. shares in India?
What is the share price of Fate Therapeutics, Inc.?
What is the 5 year returns of Fate Therapeutics, Inc.?
What are the high & low stock price of Fate Therapeutics, Inc. today?
What is the 52-week high and low of Fate Therapeutics, Inc. stock?